SEC Tracker
Get the app

Mallinckrodt

Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
Exhibit 99.1
Press release
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Mallinckrodt files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. America Great Health AAGH
  2. Nika Pharmaceuticals NIKA
  3. Regenerex Pharma RGPX
  4. CNBX Pharmaceuticals CNBX public float $252K, Aug 31, 2025
  5. NovAccess Global XSNX public float $338K, Mar 31, 2025, over 18 months old

Data on this page was fetched . The filing on SEC.gov is the record.